BP-1-102
BP-1-102 is a potent and selective oral STAT3 inhibitor that disrupts STAT3 activation by binding with high affinity (Kd: 504 nM) . It effectively suppresses the growth, survival, and invasion of STAT3-dependent cancer cells in vitro by downregulating key oncogenic targets like c-Myc and VEGF, and has demonstrated antitumor efficacy in vivo models.
Product Specifications
CAS Number
1334493-07-0
Product Name Alternative
BP 1 102, BP1102, BP-1-102, Inhibitor, inhibit, STAT, STAT3
Field of Research
Cancer Biology, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.61% (May vary between batches)
Solubility
DMSO:93 mg/mL (148.42 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (5.27 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
CN (CC (=O) N (Cc1ccc (cc1) C1CCCCC1) c1ccc (C (O) =O) c (O) c1) S (=O) (=O) c1c (F) c (F) c (F) c (F) c1F
Molecular Formula
C29H27F5N2O6S
Molecular Weight
626.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10349782 96 Well
Guinea Pig Pancreatic triacylglycerol lipase (PNLIP) ELISA Kit
Sign In for Pricing
View Details